Related references
Note: Only part of the references are listed.Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
Ferdinandos Skoulidis et al.
CLINICAL CANCER RESEARCH (2017)
Rewiring human cellular input-output using modular extracellular sensors
Kelly A. Schwarz et al.
NATURE CHEMICAL BIOLOGY (2017)
A light- and calcium-gated transcription factor for imaging and manipulating activated neurons
Wenjing Wang et al.
NATURE BIOTECHNOLOGY (2017)
Genomic alterations of ERBB receptors in cancer: clinical implications
Rosalin Mishra et al.
ONCOTARGET (2017)
Review: Oncolytic virotherapy, updates and future directions
Christos Fountzilas et al.
ONCOTARGET (2017)
Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy
Lior Nissim et al.
CELL (2017)
Advancing therapeutic applications of synthetic gene circuits
Yasutomi Higashikuni et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
Mammalian synthetic biology in the age of genome editing and personalized medicine
Patrick Ho et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Michael F. Naso et al.
BIODRUGS (2017)
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
Frederick J. Kohlhapp et al.
CLINICAL CANCER RESEARCH (2016)
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Leonardo Morsut et al.
CELL (2016)
Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer
Mohamed Alsharedi et al.
MEDICAL ONCOLOGY (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation
Max A. Horlbeck et al.
ELIFE (2016)
Quantification of Epidermal Growth Factor Receptor Expression Level and Binding Kinetics on Cell Surfaces by Surface Plasmon Resonance Imaging
Fenni Zhang et al.
ANALYTICAL CHEMISTRY (2015)
ErbB-targeted CAR T-cell immunotherapy of cancer
Lynsey M. Whilding et al.
IMMUNOTHERAPY (2015)
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann et al.
NATURE (2015)
Tunable and reversible drug control of protein production via a self-excising degron
Hokyung K. Chung et al.
NATURE CHEMICAL BIOLOGY (2015)
Highly efficient Cas9-mediated transcriptional programming
Alejandro Chavez et al.
NATURE METHODS (2015)
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer
M. A. Socinski
CURRENT ONCOLOGY (2014)
Synthetic therapeutic gene circuits in mammalian cells
Haifeng Ye et al.
FEBS LETTERS (2014)
New viruses for cancer therapy: meeting clinical needs
Tanner S. Miest et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Synthetic biology in mammalian cells: next generation research tools and therapeutics
Florian Lienert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Physiological Epidermal Growth Factor Concentrations Activate High Affinity Receptors to Elicit Calcium Oscillations
Beatrice Marqueze-Pouey et al.
PLOS ONE (2014)
EGFR Phosphorylates Tumor-Derived EGFRvIll Driving STAT3/5 and Progression in Glioblastoma
Qi-Wen Fan et al.
CANCER CELL (2013)
Architecture and Membrane Interactions of the EGF Receptor
Anton Arkhipov et al.
CELL (2013)
EGFR and HER2 inhibition in pancreatic cancer
Naomi Walsh et al.
INVESTIGATIONAL NEW DRUGS (2013)
DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety
Katrin Friedrich et al.
MOLECULAR THERAPY (2013)
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Yong Zheng et al.
NATURE (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Fast rebinding increases dwell time of Src homology 2 (SH2)-containing proteins near the plasma membrane
Dongmyung Oh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
Davide Torti et al.
EMBO MOLECULAR MEDICINE (2011)
High-level expression by tissue/cancer-specific promoter with strict specificity using a single-adenoviral vector
Yumi Kanegae et al.
NUCLEIC ACIDS RESEARCH (2011)
High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
Jin Hee Kim et al.
PLOS ONE (2011)
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action
Lisa DeFazio-Eli et al.
BREAST CANCER RESEARCH (2011)
Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells
Noga Kozer et al.
PHYSICAL BIOLOGY (2011)
Spatio-temporal modeling of signaling protein recruitment to EGFR
Ming-yu Hsieh et al.
BMC SYSTEMS BIOLOGY (2010)
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis
Dominik E. Dorer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Understanding and circumventing resistance to anticancer monoclonal antibodies
Lina Reslan et al.
MABS (2009)
Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells
S. Choi et al.
XENOBIOTICA (2009)
Colony-stimulating factors in inflammation and autoimmunity
John A. Hamilton
NATURE REVIEWS IMMUNOLOGY (2008)
The genetic design of signaling cascades to record receptor activation
Gilad Barnea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification
Takafumi Okabe et al.
CANCER RESEARCH (2007)
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
Xiao Tong et al.
ANTIVIRAL RESEARCH (2006)
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones et al.
NATURE (2006)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
HER2/Neu: mechanisms of dimerization/oligomerization
PJ Brennan et al.
ONCOGENE (2000)
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer
D Fattori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
